Description

BSE announces commencement of trading in Rights Entitlements (REs) for Healthcare Global Enterprises Limited from March 11, 2026, with renunciation trading permitted until March 20, 2026.

Summary

BSE has notified trading members that Rights Entitlements (REs) for the renunciation of Healthcare Global Enterprises Limited will be available for trading on the Exchange effective Wednesday, March 11, 2026. The REs are assigned Scrip Code 751095 and Scrip ID HCG-RE, and shall be settled on a T+1 rolling settlement basis on a trade-for-trade basis.

Key Points

  • Trading in Rights Entitlements (REs) for renunciation commences on March 11, 2026
  • Trading period for renunciation: March 11, 2026 to March 20, 2026
  • Rights Issue open period: March 11, 2026 to March 25, 2026
  • Scrip Code: 751095 | Scrip ID: HCG-RE | ISIN: INE075I20017
  • Market Lot: 1 | Group: R
  • Settlement on T+1 Rolling Settlement basis, trade-for-trade
  • REs are tradable in dematerialized form only
  • REs neither subscribed nor renounced by the Issue Closing Date shall lapse and be extinguished

Regulatory Changes

No new regulatory changes introduced. This notice follows existing framework outlined in notice no. 20200305-21 dated March 05, 2020 and notice no. 20200518-34 dated May 18, 2020 regarding Rights Entitlements trading.

Compliance Requirements

  • Trading members must inform all clients about the commencement of RE trading, mentioning the ISIN (INE075I20017)
  • Members must clarify that REs shall not be mistaken for ordinary shares of Healthcare Global Enterprises Limited
  • Contract notes/bills for RE purchases must prominently include a disclaimer stating that purchasing REs only grants the right to participate in the ongoing Rights Issue or renounce the REs before issue closure
  • Members must ensure clients are aware that unsubscribed and unrenounced REs will lapse after the Issue Closing Date

Important Dates

  • March 11, 2026: Commencement of RE trading; Rights Issue opens
  • March 20, 2026: Last day for renunciation trading of REs
  • March 25, 2026: Rights Issue closes; unrenounced and unsubscribed REs lapse after this date

Impact Assessment

This circular has a medium impact, primarily affecting existing shareholders of Healthcare Global Enterprises Limited who wish to renounce their rights entitlements. Trading members have a short operational window (March 11–20) to facilitate RE transactions. The trade-for-trade and T+1 settlement mechanism limits speculative activity. Clients purchasing REs must be clearly informed of their limited rights to avoid confusion with ordinary equity shares.

Impact Justification

Routine rights entitlement trading notice affecting existing shareholders of Healthcare Global Enterprises Limited; limited to a specific trading window and relevant primarily to current shareholders participating in the rights issue.